Amit Sachdev - 24 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Joy Liu, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
24 Feb 2023
Net transactions value
-$713,548
Form type
4
Filing time
28 Feb 2023, 16:02:04 UTC
Previous filing
22 Feb 2023
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $713,548 -2,468 -3.6% $289.12 66,518 24 Feb 2023 Direct
holding VRTX Common Stock 882 24 Feb 2023 401(k)
holding VRTX Common Stock 8,861 24 Feb 2023 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.